BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 38733529)

  • 1. Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance.
    Ashrafizadeh M; Dai J; Torabian P; Nabavi N; Aref AR; Aljabali AAA; Tambuwala M; Zhu M
    Cell Mol Life Sci; 2024 May; 81(1):214. PubMed ID: 38733529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional roles of circular RNAs during epithelial-to-mesenchymal transition.
    Shang BQ; Li ML; Quan HY; Hou PF; Li ZW; Chu SF; Zheng JN; Bai J
    Mol Cancer; 2019 Sep; 18(1):138. PubMed ID: 31526370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
    Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
    Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis.
    Yuan C; Luo X; Zhan X; Zeng H; Duan S
    Int J Mol Med; 2020 Jun; 45(6):1697-1710. PubMed ID: 32236616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells.
    Mahmoudian RA; Akhlaghipour I; Lotfi M; Shahidsales S; Moghbeli M
    Pathol Res Pract; 2023 May; 245():154472. PubMed ID: 37087995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling.
    Luo GC; Chen L; Fang J; Yan ZJ
    Bioengineered; 2021 Dec; 12(2):11089-11107. PubMed ID: 34852706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_101882 promotes migration and invasion of gastric cancer cells by regulating EMT.
    Yin GH; Gao FC; Tian J; Zhang WB
    J Clin Lab Anal; 2019 Nov; 33(9):e23002. PubMed ID: 31420917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
    Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
    EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
    Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
    Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-Associated circRNAs as Key Regulators of EMT in Cancer.
    Amicone L; Marchetti A; Cicchini C
    Cells; 2022 May; 11(10):. PubMed ID: 35626752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs in Cancer Cell Plasticity.
    Xu J; Liu S
    Adv Exp Med Biol; 2016; 927():173-89. PubMed ID: 27376735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation.
    Zhang X; Wu N; Wang J
    Cell Oncol (Dordr); 2021 Dec; 44(6):1373-1386. PubMed ID: 34738200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance.
    Hashemi M; Hajimazdarany S; Mohan CD; Mohammadi M; Rezaei S; Olyaee Y; Goldoost Y; Ghorbani A; Mirmazloomi SR; Gholinia N; Kakavand A; Salimimoghadam S; Ertas YN; Rangappa KS; Taheriazam A; Entezari M
    Pharmacol Res; 2022 Dec; 186():106535. PubMed ID: 36334877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolysis in human cancers: Emphasis circRNA/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy.
    Alkhathami AG; Sahib AS; Al Fayi MS; Fadhil AA; Jawad MA; Shafik SA; Sultan SJ; Almulla AF; Shen M
    Environ Res; 2023 Oct; 234():116007. PubMed ID: 37119844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of circular RNAs in therapy resistance of patients with solid tumors.
    Papatsirou M; Artemaki PI; Scorilas A; Kontos CK
    Per Med; 2020 Nov; 17(6):469-490. PubMed ID: 33052780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data.
    Gao Y; Shang S; Guo S; Li X; Zhou H; Liu H; Sun Y; Wang J; Wang P; Zhi H; Li X; Ning S; Zhang Y
    Nucleic Acids Res; 2021 Jan; 49(D1):D1251-D1258. PubMed ID: 33219685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
    Vadlamudi Y; Dey DK; Kang SC
    Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.